作者: Hans J Stauss , Emma C Morris , Hinrich Abken
DOI: 10.1016/J.COPH.2015.08.006
关键词: Medicine 、 Antigen 、 T-cell receptor 、 Cancer research 、 Chimeric antigen receptor 、 B cell 、 Cytotoxic T cell 、 Streptamer 、 Antigen-presenting cell 、 Immunology 、 Major histocompatibility complex
摘要: Viral and non-viral gene transfer technologies have been used to efficiently generate therapeutic T cells with desired cancer-specificity. Chimeric antigen receptors (CARs) redirect cell specificity toward antibody-recognized antigens expressed on the surface of cancer cells, while (TCRs) extend range targets include intracellular tumor antigens. CAR redirected specific for B differentiation CD19 shown dramatic efficacy in treatment malignancies, TCR-redirected benefits patients suffering from solid cancer. In this review we will present strategies optimize TCR function, discuss importance target selection enhance specificity, reducing on-target off-target toxicity.